Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Rigel Pharmaceuticals Cash on Hand 2010-2025 | RIGL

Rigel Pharmaceuticals cash on hand from 2010 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  
Rigel Pharmaceuticals Annual Cash on Hand
(Millions of US $)
2024 $77
2023 $57
2022 $58
2021 $125
2020 $57
2019 $98
2018 $129
2017 $116
2016 $75
2015 $126
2014 $143
2013 $212
2012 $298
2011 $248
2010 $177
2009 $133
Rigel Pharmaceuticals Quarterly Cash on Hand
(Millions of US $)
2025-03-31 $77
2024-12-31 $77
2024-09-30 $61
2024-06-30 $49
2024-03-31 $50
2023-12-31 $57
2023-09-30 $62
2023-06-30 $64
2023-03-31 $59
2022-12-31 $58
2022-09-30 $82
2022-06-30 $89
2022-03-31 $108
2021-12-31 $125
2021-09-30 $143
2021-06-30 $153
2021-03-31 $39
2020-12-31 $57
2020-09-30 $73
2020-06-30 $92
2020-03-31 $96
2019-12-31 $98
2019-09-30 $107
2019-06-30 $112
2019-03-31 $128
2018-12-31 $129
2018-09-30 $116
2018-06-30 $135
2018-03-31 $94
2017-12-31 $116
2017-09-30 $68
2017-06-30 $82
2017-03-31 $98
2016-12-31 $75
2016-09-30 $85
2016-06-30 $95
2016-03-31 $104
2015-12-31 $126
2015-09-30 $134
2015-06-30 $144
2015-03-31 $161
2014-12-31 $143
2014-09-30 $158
2014-06-30 $176
2014-03-31 $195
2013-12-31 $212
2013-09-30 $231
2013-06-30 $252
2013-03-31 $272
2012-12-31 $298
2012-09-30 $184
2012-06-30 $203
2012-03-31 $223
2011-12-31 $248
2011-09-30 $266
2011-06-30 $279
2011-03-31 $156
2010-12-31 $177
2010-09-30 $168
2010-06-30 $187
2010-03-31 $110
2009-12-31 $133
2009-09-30 $156
2009-06-30 $80
2009-03-31 $105
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.333B $0.179B
Rigel Pharmaceuticals, Inc. is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases. Its goal is to file one new investigative new drug application in a significant indication each year. The Company's pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidates. We have product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia, and asthma and allergy, as well as in cancer.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $85.731B 32.16
Zoetis (ZTS) United States $70.000B 26.12
Takeda Pharmaceutical (TAK) Japan $47.633B 9.47
Daiichi Sankyo, - (DSNKY) Japan $43.873B 22.49
BeOne Medicines - (ONC) Cayman Islands $29.277B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.324B 0.00
Merck (MKKGY) Germany $16.717B 12.25
Summit Therapeutics (SMMT) United States $15.797B 0.00
Shionogi (SGIOY) Japan $14.785B 14.81
United Therapeutics (UTHR) United States $12.899B 11.41
Neurocrine Biosciences (NBIX) United States $12.646B 43.31
Orion OYJ (ORINY) Finland $10.469B 28.31
IPSEN (IPSEY) France $9.739B 0.00
Corcept Therapeutics (CORT) United States $7.846B 63.78
Stevanato Group S.p.A (STVN) Italy $7.647B 46.76
Ionis Pharmaceuticals (IONS) United States $6.366B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.165B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $5.851B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.382B 13.33
Soleno Therapeutics (SLNO) United States $4.323B 0.00
Hypermarcas (HYPMY) Brazil $2.977B 19.58
Crinetics Pharmaceuticals (CRNX) United States $2.847B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.627B 9.21
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.523B 13.64
NewAmsterdam Pharma (NAMS) Netherlands $2.058B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.038B 0.00
Indivior (INDV) United States $1.893B 8.03
Centessa Pharmaceuticals (CNTA) United Kingdom $1.794B 0.00
ARS Pharmaceuticals (SPRY) United States $1.695B 0.00
Endo (NDOI) United States $1.603B 0.00
Evotec AG (EVO) Germany $1.477B 0.00
Ocular Therapeutix (OCUL) United States $1.464B 0.00
Guardian Pharmacy Services (GRDN) United States $1.285B 0.00
Dyne Therapeutics (DYN) United States $1.184B 0.00
Harrow (HROW) United States $1.157B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.085B 21.70
Enliven Therapeutics (ELVN) United States $1.055B 0.00
Verve Therapeutics (VERV) United States $0.999B 0.00
Akebia Therapeutics (AKBA) United States $0.967B 0.00
Collegium Pharmaceutical (COLL) United States $0.957B 5.16
Avadel Pharmaceuticals (AVDL) Ireland $0.913B 0.00
Ardelyx (ARDX) United States $0.869B 0.00
Elite Pharmaceuticals (ELTP) United States $0.816B 0.00
Xeris Biopharma Holdings (XERS) United States $0.737B 0.00
Cronos Group (CRON) Canada $0.729B 0.00
Altimmune (ALT) United States $0.625B 0.00
Liminatus Pharma (LIMN) United States $0.624B 0.00
Xencor (XNCR) United States $0.609B 0.00
KalVista Pharmaceuticals (KALV) United States $0.581B 0.00
USANA Health Sciences (USNA) United States $0.575B 12.49
Regulus Therapeutics (RGLS) United States $0.565B 0.00
Relay Therapeutics (RLAY) United States $0.559B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.558B 0.00
Bioventus (BVS) United States $0.550B 13.94
Theravance Biopharma (TBPH) United States $0.529B 0.00
Zevra Therapeutics (ZVRA) United States $0.510B 0.00
AleAnna (ANNA) United States $0.483B 0.00
Siga Technologies (SIGA) United States $0.460B 9.61
Organogenesis (ORGO) United States $0.449B 0.00
Tourmaline Bio (TRML) United States $0.436B 0.00
Oruka Therapeutics (ORKA) United States $0.435B 0.00
Savara (SVRA) United States $0.379B 0.00
Nektar Therapeutics (NKTR) United States $0.361B 0.00
Heron Therapeutics (HRTX) United States $0.328B 0.00
Aquestive Therapeutics (AQST) United States $0.323B 0.00
Nature's Sunshine Products (NATR) United States $0.274B 25.15
Tonix Pharmaceuticals Holding (TNXP) United States $0.250B 0.00
ProKidney (PROK) United States $0.226B 0.00
Nanobiotix S.A (NBTX) France $0.214B 0.00
MediWound (MDWD) Israel $0.211B 0.00
Aldeyra Therapeutics (ALDX) United States $0.210B 0.00
Larimar Therapeutics (LRMR) United States $0.208B 0.00
OmniAb (OABI) United States $0.203B 0.00
Esperion Therapeutics (ESPR) United States $0.200B 0.00
4D Molecular Therapeutics (FDMT) United States $0.189B 0.00
Profound Medical (PROF) Canada $0.180B 0.00
Aclaris Therapeutics (ACRS) United States $0.177B 0.00
Innate Pharma SA (IPHYF) France $0.163B 0.00
Journey Medical (DERM) United States $0.162B 0.00
Galectin Therapeutics (GALT) United States $0.159B 0.00
Lexeo Therapeutics (LXEO) United States $0.139B 0.00
Lyell Immunopharma (LYEL) United States $0.138B 0.00
Achieve Life Sciences (ACHV) Canada $0.132B 0.00
Avita Medical (RCEL) United States $0.126B 0.00
Inhibikase Therapeutics (IKT) United States $0.124B 0.00
VAXART, INC (VXRT) United States $0.123B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.121B 0.00
Cardiol Therapeutics (CRDL) Canada $0.120B 0.00
Korro Bio (KRRO) United States $0.112B 0.00
Protara Therapeutics (TARA) United States $0.112B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.106B 0.00
Champions Oncology (CSBR) United States $0.105B 17.20
Arch Biopartners (ACHFF) Canada $0.091B 0.00
Cassava Sciences (SAVA) United States $0.089B 0.00
Nutriband (NTRB) United States $0.086B 0.00
Fractyl Health (GUTS) United States $0.085B 0.00
Dominari Holdings (DOMH) United States $0.081B 0.00
Pyxis Oncology (PYXS) United States $0.079B 0.00
Unicycive Therapeutics (UNCY) United States $0.079B 0.00
ESSA Pharma (EPIX) Canada $0.077B 0.00
Vivani Medical (VANI) United States $0.077B 0.00
Surrozen (SRZN) United States $0.074B 0.00
Wellgistics Health (WGRX) United States $0.066B 0.00
Inotiv (NOTV) United States $0.062B 0.00
Assertio Holdings (ASRT) United States $0.060B 0.00
Context Therapeutics (CNTX) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Gain Therapeutics (GANX) United States $0.058B 0.00
Metagenomi (MGX) United States $0.058B 0.00
Rafael Holdings (RFL) United States $0.058B 0.00
PMV Pharmaceuticals (PMVP) United States $0.057B 0.00
NRx Pharmaceuticals (NRXP) United States $0.057B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.055B 0.00
Telomir Pharmaceuticals (TELO) United States $0.053B 0.00
Avalo Therapeutics (AVTX) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.049B 0.00
Prelude Therapeutics (PRLD) United States $0.048B 0.00
Mural Oncology (MURA) Ireland $0.042B 0.00
Acrivon Therapeutics (ACRV) United States $0.042B 0.00
Iterum Therapeutics (ITRM) Ireland $0.041B 0.00
Klotho Neurosciences (KLTO) United States $0.041B 0.00
Karyopharm Therapeutics (KPTI) United States $0.039B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.038B 28.33
PolyPid (PYPD) Israel $0.038B 0.00
Jupiter Neurosciences (JUNS) United States $0.037B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.036B 0.00
Enlivex Therapeutics (ENLV) Israel $0.030B 0.00
SCYNEXIS (SCYX) United States $0.029B 0.00
China SXT Pharmaceuticals (SXTC) China $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.026B 0.00
FibroGen (FGEN) United States $0.023B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
VYNE Therapeutics (VYNE) United States $0.021B 0.00
DURECT (DRRX) United States $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
Mannatech (MTEX) United States $0.019B 0.00
Vivos Therapeutics (VVOS) United States $0.018B 0.00
Relmada Therapeutics (RLMD) United States $0.018B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
Lyra Therapeutics (LYRA) United States $0.016B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.013B 0.00
Citius Pharmaceuticals (CTXR) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.22
Cosmos Health (COSM) United States $0.013B 0.00
Crescent Biopharma (CBIO) United States $0.012B 0.00
Ainos (AIMD) United States $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Plus Therapeutics (PSTV) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Aditxt (ADTX) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00